Covington Capital Management’s Verastem VSTM Stock Holding History

Covington Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8	Closed	–	–	1199
2022 Q1	$0	Buy	+8	New	+$138	﹤0.01%	1151

Other funds holding VSTM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Covington Capital Management's VSTM Position: Q2 2022 in Review

Covington Capital Management sold out of Verastem (VSTM) in Q2 2022, closing a stake of 8 shares.

Covington Capital Management first reported a position in VSTM in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 122 funds tracked by Wall St. Rank hold VSTM as of Q2 2022.

Covington Capital Management reported no remaining Verastem position as of Q2 2022 after selling out during the quarter.
Covington Capital Management sold 8 Verastem shares in Q2 2022.
Covington Capital Management first reported a position in Verastem in Q1 2022 and held it in 1 quarter.
Covington Capital Management's Verastem position peaked at $0 in Q1 2022.
122 funds tracked by Wall St. Rank held Verastem as of Q2 2022.

Based on Covington Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.